Clinical pathology services: remapping our strategic itinerary

Area of Science:

• Clinical Pathology
• Laboratory Medicine
• Healthcare Management

Background:

• Technological and economic factors have driven significant increases in clinical laboratory testing productivity worldwide.
• However, advances in production capabilities have not been matched by improvements in optimal test utilization and interpretation by clinical pathologists.
• This disparity leads to decreased healthcare value productivity, despite higher testing output.

Purpose of the Study:

• To address the challenges posed by increased testing productivity outpacing utilization and interpretation in clinical pathology.
• To propose a proactive strategy for clinical pathology to enhance healthcare value productivity.
• To identify pathways for safeguarding and expanding the role of clinical pathologists in the evolving healthcare landscape.

Main Methods:

• A Strengths-Weaknesses-Opportunities-Threats (SWOT) analysis was conducted.
• The study examined the current state of clinical pathology in response to technological and economic drivers.
• The analysis informed recommendations for strategic shifts and operational improvements.

Main Results:

• Clinical pathology is threatened by the potential loss of control over commodity testing and the failure to optimize knowledge processes.
• Increased testing productivity has not translated into commensurate gains in healthcare value.
• A reactive strategy focused on 'more with less' is insufficient for the specialty's future.

Conclusions:

• Clinical pathology must adopt a proactive strategy, emphasizing knowledge services and operational excellence.
• Safeguarding and enhancing healthcare value productivity requires leadership in integrated laboratory services networks.
• A systems approach, including risk-based quality management, is essential for core knowledge processes.